Oncology Venture Sweden AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Claus Frisenberg Pedersen, was filed 28 Mar 2018.
Oncology Venture Sweden AB: what insiders have been doing
This page follows insider dealings at Oncology Venture Sweden AB as filed with Finansinspektionen. Oncology Venture Sweden AB has had no insider filing for more than a year; the last one goes back to 5 July 2018.
Over the whole record (from 2017), the tally stands at 2 purchases and 3 sales.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
- 662,038 shares@ SEK 15.3152.5% of flowISIN SE0007157409FI:csv-6316500835c296cd0f6e
- 465,500 shares@ SEK 15.6338.2% of flowISIN SE0007157409FI:csv-dcda011ec29bac150b21
- 41,000 shares@ SEK 16.633.6% of flowISIN SE0007157409FI:csv-ddbb3b258e5ef91296e3
- 3,700 shares@ SEK 18.36100.0% of flowISIN SE0007157409FI:csv-cbb11a97e64f14b63853Canonical exit: 24 Jun 2018 (T+90)
- 107,000 shares@ SEK 6.88100.0% of flowFI:csv-922be04e06e029d69ed3
- 100,000 shares@ SEK 10.005.7% of flowISIN SE0007157409FI:csv-4d00e50a634334add265
- 302,243 shares@ SEK 10.00100.0% of flowISIN SE0007157409FI:csv-09394d093b792e401132Canonical exit: 17 Apr 2017 (T+90)
7 of 7 declarations
About Oncology Venture Sweden AB
Oncology Venture Sweden AB is a company focused on developing innovative cancer treatments. It specializes in personalized medicine to enhance patient outcomes.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations